| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/17/2022 | 81.16% | HC Wainwright & Co. | $11 → $10 | Maintains | Buy |
| 01/31/2022 | 99.28% | HC Wainwright & Co. | $10 → $11 | Upgrades | Neutral → Buy |
| 04/09/2021 | 81.16% | HC Wainwright & Co. | $12 → $10 | Maintains | Neutral |
| 03/04/2021 | 117.39% | HC Wainwright & Co. | $24 → $12 | Downgrades | Buy → Neutral |
| 01/25/2021 | 407.25% | Roth Capital | → $28 | Initiates Coverage On | → Buy |
| 05/20/2020 | -72.83% | HC Wainwright & Co. | $2.5 → $1.5 | Reiterates | → Buy |
| 11/20/2019 | -54.71% | HC Wainwright & Co. | $3 → $2.5 | Reiterates | → Buy |
| 09/05/2019 | -80.98% | Roth Capital | $4.25 → $1.05 | Downgrades | Buy → Neutral |
| 06/19/2019 | -45.65% | HC Wainwright & Co. | → $3 | Initiates Coverage On | → Buy |
| 05/23/2018 | 207.97% | Janney Montgomery Scott | → $17 | Initiates Coverage On | → Buy |
| 02/26/2018 | 99.28% | Canaccord Genuity | $7 → $11 | Maintains | Buy |
KemPharm Questions & Answers
The latest price target for KemPharm (NASDAQ: KMPH) was reported by HC Wainwright & Co. on August 17, 2022. The analyst firm set a price target for $10.00 expecting KMPH to rise to within 12 months (a possible 81.16% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for KemPharm (NASDAQ: KMPH) was provided by HC Wainwright & Co., and KemPharm maintained their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of KemPharm, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for KemPharm was filed on August 17, 2022 so you should expect the next rating to be made available sometime around August 17, 2023.
While ratings are subjective and will change, the latest KemPharm (KMPH) rating was a maintained with a price target of $11.00 to $10.00. The current price KemPharm (KMPH) is trading at is $5.52, which is out of the analyst's predicted range.